首页

优势供应

促销产品

大货产品

最新产品

热销产品

文献产品

最新产品

结构式 货号 产品名称 CAS号
SC-1 结构式
BCP46435 SC-1 1313019-65-6
SC-1 is a a derivative of the multiple tyrosine kinase inhibitor sorafenib.
MP07-66 结构式
BCP46434 MP07-66 1938056-90-6
MP07-66, a FTY720 analogue, is devoid of immunosuppressive effects and shows promising antitumor effects in chronic lymphocytic leukemia by disruption of the SET-PP2A complex leading to PP2A reactivation.
PI-273 结构式
BCP46433 PI-273 925069-34-7
PI-273 is a first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor. It can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
SPP-86 结构式
BCP46432 SPP-86 1357349-91-7
SPP-86 is a potent RET inhibitor.
DATP-N3 结构式
BCP46395 DATP-N3 1048021-78-8
Fenquizone 结构式
BCP46379 芬喹唑 20287-37-0
Fenquizone is a member of quinazolines.
Gilmelisib 结构式
BCP46378 Gilmelisib 1845777-61-8
Gilmelisib is a PI3K inhibitor and antineoplastic.
TC-FPR 43 结构式
BCP46377 TC-FPR 43 903895-98-7
TC-FPR 43 is a potent formyl peptide receptor 2 (FPR2) agonist.
WAY-204688 结构式
BCP46376 WAY-204688 796854-35-8
WAY-204688 is a selective and orally active estrogen receptor inhibitor of NF-κB transcriptional activity (IC50: 122 ± 30 nM for NF-κB-luciferase in HAECT-1 cells).
PA 452 结构式
BCP46369 PA 452 457657-34-0
PA 452 is an RXR antagonist.
SR 13800 结构式
BCP46368 SR 13800 227321-12-2
SR 13800 is a cell-permeable inhibitor of monocarboxylate transporter 1 (MCT1).
NLG802 结构式
BCP46357 NLG802 2071683-99-1
NLG802 is a prodrug of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.
(3S)-3-(2,2,2-Trifluoroethyl)pyrrolidine 结构式
BCP46323 (3S)-3-(2,2,2-三氟乙基)吡咯烷 1430091-57-8
M-525 结构式
BCP46311 M-525 2173582-08-4
M-525 is a first-in-class, highly potent, irreversible small-molecule inhibitor of the menin-MLL interaction.
Pacmilimab 结构式
BCP46429 帕克米利单抗 2145091-51-4
Pacmilimab (CX-072) is a Probody therapeutic directed against PD-L1.
Odronextamab 结构式
BCP46428 奥尼妥单抗 1801338-64-6
Odronextamab is a hinge-stabilised, fully human IgG4-based CD20 × CD3 bispecific antibody that binds CD3 on T cells and CD20 on B cells.
Nurulimab 结构式
BCP46427 诺瑞利单抗 2168561-20-2
Nurulimab is a biosimilar that targets CTLA4.
Mirzotamab 结构式
BCP46426 米佐妥单抗 2229859-11-2
Mirzotamab is a biosimilar that targets CD276.
Mavezelimab 结构式
BCP46422 玛维泽利单抗 2231068-83-8
Mavezelimab is a biosimilar that targets LAG3.
Lodapolimab 结构式
BCP46420 洛达利单抗 2118349-31-6
Lodapolimab is a biosimilar that targets PDCD1/PD-1/CD279.
123下一页末页共 15148 条记录 1 / 758 页 
2853530911